8-K: Recursion Pharmaceuticals, Inc. — Item 1.01 Entry into a Material Definitive Agreement
Filed: 2026-10-15 AccNo: 0001601830-26-000128 Size: 8 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.02: Results of Operations and Financi
Filed: 2026-10-15 AccNo: 0001601830-26-000128 Size: 8 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.02: Results of Operations and Financi